Clinical Trials Browser

Interventional × belumosudil × 90 days × Clear all

NCT07006506 2026-03-05

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Phase 2 Recruiting

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms